Roivant Sciences
The Senior Analyst / Associate on Roivant’s Commercial team will build and lead commercialization functions for multiple medicines, handling market research, KOL engagement, real‑world data analysis, financial modeling, and competitive diligence. The role involves end‑to‑end ownership of workstreams, delivering strategic recommendations, and collaborating with senior leadership and cross‑functional stakeholders.
Headquarters
New York, New York, United States
Company Size
201-500 employees
Founded
2014
Roivant is a healthcare company focused on improving patient outcomes by rapidly developing and delivering innovative medicines and health technologies. It builds and partners with nimble, entrepreneurial subsidiaries called "Vants"—biotech and healthcare technology companies that operate with a platform approach to source specialized talent, align incentives, and deploy technology. Roivant supports drug development, licensing and commercialization across therapeutic areas using shared infrastructure and focused teams. Its model emphasizes speed, operational efficiency and scalable, tech-enabled capabilities to bring therapies to patients faster.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Roivant Sciences.
6% above the average for this role
A Roivant spinout bets on AI-designed drugs for immune conditions
Dec 10, 2025